Top 5 Analysts to Watch Ahead of Gilead Sciences, Inc’s (GILD) Earnings
By Sarah Roden Gilead Sciences, Inc. (NASDAQ:GILD) will release second quarter earnings on Tuesday, July 28 after the bell. The biopharmaceutical giant is most known for its hepatitis C drugs, Harvoni and Sovaldi. Several analysts weighed in on Gilead after the company posted a strong earnings report in May. Here are the top 5 analysts … Read more